20 May 2013
Keywords: first, approvals, zeneca, glaxo, wellcome, migraine, products
Article | 11 March 1997
The migraine market has seen a phenomenal rate of growth over the lastfew years to become a billion dollar-plus market ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 March 1997
25 March 1997
© 2013 thepharmaletter.com